http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-174415-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e67b5c03c14e268aeecae4d5f1a261d6
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B41-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B43-04
filingDate 2016-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f389d9ee40dbac63b902ce9fcb390143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4e0b1d36abffdd72d6e2ba3c6deea24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04bd1989f899ee7376957e4e9eee83cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54078c9a928cffc3f63c67c1697a9314
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ac0051c95d9f7e2a3eab56ede5f14c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d9680ff9f70b31c39ef88d4c1977008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b61dbba8fe36d83aed67db978308f109
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2312e281ecf8a3d11b0449e76fece638
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd0f816c9a765c16ee4f092f7357d598
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5e10cc39699672d7762ef9d25fa7aee
publicationDate 2020-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MY-174415-A
titleOfInvention Salt form, crystal form and intermediate of 1,2,5-thiadiazolidine-1,1-dioxide and preparation method thereof
abstract The present invention discloses a salt form, crystal form and intermediate of the compound 1, and preparation method thereof.
priorityDate 2015-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426159606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10464345

Total number of triples: 30.